BHF-177

From WikiMD's WELLNESSPEDIA

BHF-177 is a drug that is used in scientific research. It is a GABAB receptor antagonist, which means it blocks the action of the GABAB receptor. This receptor is a type of G protein-coupled receptor that is found in the central nervous system and plays a role in inhibitory neurotransmission.

Pharmacology[edit]

BHF-177 is a GABAB receptor antagonist. The GABAB receptor is a type of G protein-coupled receptor that is found in the central nervous system. It is involved in inhibitory neurotransmission, which means it reduces the activity of neurons. By blocking the action of the GABAB receptor, BHF-177 can increase neuronal activity.

Uses[edit]

BHF-177 is used in scientific research to study the role of the GABAB receptor in the central nervous system. It can be used to investigate the effects of inhibitory neurotransmission and to explore potential treatments for conditions that involve abnormal GABAB receptor activity.

Side Effects[edit]

As a research drug, BHF-177 is not used in humans and therefore its side effects are not known. However, because it increases neuronal activity, it could potentially cause side effects related to overstimulation of the nervous system.

See Also[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

  • BHF-177 Structure
    BHF-177 Structure

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=BHF-177&oldid=6331075"